Silenor Withdrawal and Tapering Help
Silenor is a tricyclic antidepressant that was marketed as having no discontinuation syndrome yet patient reporting has shown it is similar to other antidepressants. Our NonProfit has been helping people withdraw safely for
over 15 Years.
the Prescription Drug Experts for help!
Point of Return Can Help You
The Point of Return Program is an in-home tapering program that allows you to gradually lessen the amount of Silenor while also implementing the use of all-natural, calming nutraceuticals to help ease symptoms. We eliminate
Interaction items to help make Silenor withdrawal more comfortable. Our physician recommended schedules allow your doctor to taper you off Silenor correctly. The success of our program over the past
15 years is due to our unmatched service and unique mentoring approach. Silenor can be dangerous to abruptly or rapidly stop and our program is a proven, viable, low-cost option to continue living your life while tapering.
Read program FAQ page.
We are experts that specialize in Antidepressant withdrawals.
Key Components of Our In-Home Program
- Skilled Experts guiding you throughout the process
Assessment at the onset to determine a gameplan
*Nutraceuticals specially formulated to help ease symptoms, these are utilized throughout the whole process
- Unlike herbs and many vitamins, our nutraceuticals will not interact with any medications
24/7 discussion board with encouraging members and knowledgeable mentors
Recommendations for addressing symptoms
- Experienced team of committed experts with over 15 years experience
Break Free Today
At Point of Return, a 501(c)3 nonprofit, we have spent the last 15 years helping people wean off prescription medications correctly. With customized taper rates and all natural nutraceuticals, our program allows you to come off Silenor, once and for all, from the comfort of your home.
Read program FAQs.
" I owe it all to you, and everyone else at Point of Return. Thank you for all your hard work, and your perseverance, and your blood, sweat, and tears. I can promise you, that it is all worth it! I am forever grateful, and I will never stop telling people about Point of Return. more...
Reach out for help
Silenor history and info
Silenor is a psychotropic agent with antidepressant and anti-anxiety properties. A study published in JAMA internal Medicine in early 2015 found Silenor (Sinequan) increased the risk of developing dementia.
Because Silenor also blocks the neurotransmitter Acetylcholine, it is not recommended for patients with a history of glaucoma, increased intraocular pressure or urinary retention. Like all Tricyclic antidepressants, when given in high doses, Silenor can induce sinus tachycardia, changes in conduction time and arrhythmias of the heart.
All Antidepressants can cause withdrawal symptoms if abruptly stopped or tapered too rapidly and Silenor is no different. It is recommended to taper slowly.
Sinequan (Silenor) is a psychotropic agent with antidepressant and anti-anxiety properties that was developed by Boehringer-Ingelheim, now part of the Roche group. Sinequan was tested from 1963-1968 in different German and Swiss psychiatric institutions and was approved in Germany initially, then in other countries.
Silenor is a Tricyclic Antidepressant that exerts its action on Serotonin and Norepinephrine but also blocks Dopamine and the histamine receptors. Histamine is involved in the immune response and Dopamine is a critical neurotransmitter that plays important roles in both the brain and body. Serotonin is primarily found in the gastrointestinal tract, central nervous system and in the blood platelets while Norepinephrine works as both a hormone and a neurotransmitter, stimulating the heart, sweat glands, blood vessels, large internal organs and the adrenals whereas Serotonin is involved in sleep, memory, regulation of the endocrine system, body temperature, mood and behavior and muscle movement.
Like all Tricyclic antidepressants, when given in high doses, Silenor can induce sinus tachycardia, changes in conduction time and arrhythmias of the heart. A few instances of unexpected death have been reported in patients with cardiovascular disorders. Myocardial infarction and stroke have also been reported with drugs of this class. Therefore, Silenor should be administered with extreme caution to patients with a history of cardiovascular disease, those with circulatory issues and elderly patients. Since Tricyclic agents are known to reduce the seizure threshold, Silenor should be used with caution in patients with a history of convulsive disorders.
*While great care has been taken in organizing and presenting the material throughout this website, please note that it is provided for informational purposes only and should not be taken as Medical Advice.
*The statements on this website have not been evaluated by the Food and Drug Administration (FDA). The products and labels mentioned / sold are not intended to diagnose, treat, cure, or prevent any disease or illness.
* Testimonial results may vary person to person.
*The program outlined in Point of Return is not meant to substitute your doctor, instead it is to be utilized with your physician to help you with your drug withdrawal process and with his or her consent.
*Because prescription medications can cause severe withdrawal reactions, do not stop taking any medication without first consulting your physician. The decision to taper any medication should be discussed with your doctor and done with their consent and support. More...